School of Medicine
Showing 10,541-10,560 of 12,906 Results
-
Stephen J Smith
Professor of Molecular and Cellular Physiology, Emeritus
Current Research and Scholarly InterestsStephen Smith remains active in the computational microscopy field and is also currently using data science tools to explore new transcriptomic perspectives on signaling by neuropeptides and other neuromodulators in brains of diverse animal species. These exploration have unearthed evidence for a previous unrecognized ubiquity of local neuropeptide signaling and possible critical involvement of such signaling in memory engram formation.
-
Stephen Smith, MD
Clinical Assistant Professor, Ophthalmology
Current Research and Scholarly InterestsRESEARCH OVERVIEW
Dr. Smith’s primary professional interest is developing solutions for unmet clinical and surgical vitreoretinal needs. Beginning in medical school, one of his primary focuses has been improving treatment outcomes in patients with retinoblastoma (RB). During his second year in medical school Dr. Smith published a manuscript on a novel technique to reduce the risk of tumor spread following intravitreal drug delivery in patients with RB. His work summarizing published data on tumor spread following intravitreal injection therapy (IVT) for RB has resulted in multiple platform presentations at national and international meetings, including an invited lecture at ARVO 2014. The results of this study influenced the growing trend toward broader acceptance of intravitreal chemotherapy in pediatric patients with treatment-resistant retinoblastoma vitreous seeds. A primary active area of research has included studying and publishing on ocular toxicity that results from the use of intravitreal melphalan and other agents for RB. This work, and subsequent publications from leaders in the field, has led to an increased awareness of ocular toxicity caused by injecting chemotherapeutic agents into the eyes of young children. This highlighted the need for toxicity data on additional chemotherapeutic agents for local delivery. To answer this question, Dr. Smith assembled an excellent group of collaborators and consultants, including internationally known experts at Bascom Palmer, Mayo Clinic, and Emory University. As a resident he secured a highly competitive career starter grant from the Knights Templar Foundation and used that funding and the expertise of his collaborators to carry out preclinical ocular toxicity studies of combination intravitreal chemotherapy for RB. His work in RB has led to a broader recognition of the challenges facing patients with RB who receive IVT and has led to a continued search for optimal local injectable therapies for patients with this disease.
INNOVATION HIGHLIGHTS
In addition to his work in retinoblastoma, Dr. Smith has been actively involved in developing technologies to improve outcomes for patients receiving intravitreal injection therapy (IVT) for macular degeneration, diabetic retinopathy, retinal vein occlusions and more. IVT has become the most common procedure performed by retina specialists in the United States, with an estimated 6 million injections given in the United States alone in 2016. Dr. Smith has co-developed technology that simplifies and streamlines the IVT process, removing barriers to treatment and improving patient outcomes. His work in innovation covers pre-clinical and clinical development work, and has given him expertise in diverse subject areas including fundraising, intellectual property portfolio development, team building, and business administration. He is a co-founder of iRenix Medical, a biotechnology and medical device start-up company committed to improving vision through optimization of the IVT process.
Dr. Smith remains dedicated to helping improve and restore vision and quality of life in patients with vitreoretinal disease. He is currently involved in both medical device and pharmaceutical innovation, and serves as a mentor for the Stanford University Biodesign Innovation Course. -
Rebecca Smith-Coggins, MD
Professor (Teaching) of Emergency Medicine, Emerita
Current Research and Scholarly InterestsEffect of work schedule on work performance, mood and, sleep architecture in attending emergency medicine physicians,residents.
-
Matthew Smuck, MD
Professor of Orthopaedic Surgery
On Partial Leave from 03/11/2026 To 04/17/2026Current Research and Scholarly InterestsI direct the Wearable Health Lab at Stanford, investigating medical applications of mobile technology to improve musculoskeletal and neurologic disease detection, treatment and prevention.
-
Blake Marleau Snyder
Clinical Instructor, Ophthalmology
BioBlake Snyder, MD grew up in Colorado and brings his love of skiing, biking, hiking, and live music to a life and career focused on global ophthalmology. He studied biochemistry and chemistry at the University of Colorado, graduating summa cum laude as the only student in his department to do so, with distinction and Phi Beta Kappa honors. He then spent a year as an Intramural Research Training Award Fellow at the National Institutes of Health, where he was first introduced to ophthalmology. During medical school, he was one of six students selected as an AOA Honor Society leader and received both the departmental award in ophthalmology at graduation and a full presidential scholarship. He spent two years completing international ophthalmology research as a Doris Duke/Fogarty Fellow with the Francis I. Proctor Foundation at UCSF, contributing to a project later supported by the Bill & Melinda Gates Foundation. He completed residency at UC Davis, where he served as Chief Resident and co-authored a policy paper that helped advance Congressional legislation on corneal donation access for minority populations. He returned to UCSF and the Proctor Foundation for fellowship training in uveitis and medical cornea and is now a Global Ophthalmology Fellow at Stanford.
-
Michael Snyder, Ph.D.
Stanford W. Ascherman Professor of Genetics
Current Research and Scholarly InterestsOur laboratory use different omics approaches to study a) regulatory networks, b) intra- and inter-species variation which differs primarily at the level of regulatory information c) human health and disease. For the later we have established integrated Personal Omics Profiling (iPOP), an analysis that combines longitudinal analyses of genomic, transcriptomic, proteomic, metabolomic, DNA methylation, microbiome and autoantibody profiles to monitor healthy and disease states
-
Samuel So, MD
Lui Hac Minh Professor in the School of Medicine
Current Research and Scholarly InterestsThrough a 4 pronged comprehensive program: translational and clinical research, early detection and treatment, promoting education, awareness and immunization and building partnership, we are working towards the development of new strategies that will lead to the elimination of hepatitis B worldwide and reduce the threat and incidence of liver cancer. Current research efforts focus on evaluating potential new diagnostic and treatment markers and novel targeted therapy for primary liver cancer.
-
Yuen So, MD, PhD
Professor of Neurology and Neurological Sciences (Adult Neurology), Emeritus
Current Research and Scholarly InterestsResearch in the diagnosis, pathophysiology and treatment of peripheral neuropathy, myasthenia gravis, motor neuron diseases including ALS and SMA, nerve injuries and muscle diseases. Application of clinical neurophysiological methods to neurological diagnosis. Development of evidence-based medicine pertaining to the practice of neurology.
-
Bruno Passebon Soares, MD
Associate Professor of Radiology (Pediatric)
BioDr. Soares is an Associate Professor of Radiology at Stanford University School of Medicine and serves as the Section Chief of Pediatric Neuroradiology at Lucile Packard Children’s Hospital at Stanford since June 2023.
Born in Brazil, Dr. Bruno P. Soares obtained his medical degree from the Federal University of Rio de Janeiro and completed his residency in Diagnostic Radiology at the Federal University of Sao Paulo. After one year as a Research Fellow at the University of California San Francisco (UCSF), Dr. Soares completed clinical fellowships in Diagnostic Neuroradiology, Pediatric Radiology, and Pediatric Neuroradiology at UCSF, in addition to a clinical fellowship in PET/CT at the Dana-Farber Cancer Institute of Harvard Medical School in Boston. Dr. Soares holds a subspecialty certificate in Neuroradiology from the American Board of Radiology (ABR).
From July 2013 to July 2016, Dr. Soares was an Assistant Professor in the Division of Neuroradiology at Emory University in Atlanta. From August 2016 to November 2018, he worked at the Johns Hopkins University in Baltimore as an Assistant Professor in the Division of Pediatric Radiology and Neuroradiology. From December 2018 to May 2023, Dr. Soares worked at the University of Vermont Medical Center as Associate Professor of Radiology, Division Chief of Neuroradiology, Vice-Chair of Imaging Research, and Co-Director of the MRI Center for Biomedical Imaging.
Dr. Soares has published more than 85 peer-reviewed articles and has been the recipient of the Research Fellow Grant from the Society for Pediatric Radiology and of the Rad_Britestar Award from the Johns Hopkins Department of Radiology. The recognition for his teaching includes the 2013 Outstanding Clinical Fellow / Instructor Teaching Award from the UCSF Department of Radiology, the 2017 Teacher of Year Award from the Johns Hopkins Division of Pediatric Radiology, and the 2017 ASNR International Outreach Professor Program in Ghana.
Dr. Soares currently serves as an Editorial Board Member of Neuroradiology and of the Journal of Neuroimaging, and has served as an Editorial Board Member of the American Journal of Roentgenology (AJR) and of the American Journal of Neuroradiology (AJNR). Dr. Soares served for six years as a member of the ABR Neuroradiology Core Exam Committee, receiving ABR Volunteer Service Awards in 2022 and 2024.
His research has focused on neonatal and pediatric brain imaging. He is currently focused on developing semi-automated algorithms to quantify normal and abnormal brain development, and applying deep learning algorithms for detection of subtle cerebral abnormalities in children with epilepsy. -
Raymond A. Sobel, M.D.
Professor of Pathology
Current Research and Scholarly InterestsWe study cellular and molecular mechanisms of immune-mediated injury in CNS tissues that are affected in multiple sclerosis (MS). We study: 1) tissues of mice with EAE using histology and immunohistochemistry, 2) cross-recognition of neurons by antibodies against myelin proteolipid protein epitopes, and a distinct oligodendrogliopathy induced in mice by the non-protein amino acid azetidine (Aze), (which is found in the human diet); Aze-induced abnormalities mimic those in MS patient CNS tissues
